Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Insights and Forecast to 2028

Publisher Name :
Date: 22-Feb-2022
No. of pages: 88
Inquire Before Buying

Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

PCR

In-situ Hybridization

Immunohistochemistry

Sequencing

Others

Segment by Application

Oncology

Neurological Disorders

Cardiovascular Disease

Immunological Disorders

Others

By Company

Qiagen NV

GE Healthcare

Agilent Technologies

F Hoffman La Roche

Foundation Medicine

Thermo Fisher Scientific Inc.

Leica Biosystems Nussloch GmBH

Pfizer

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PCR
1.2.3 In-situ Hybridization
1.2.4 Immunohistochemistry
1.2.5 Sequencing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Neurological Disorders
1.3.4 Cardiovascular Disease
1.3.5 Immunological Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Perspective (2017-2028)
2.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Growth Trends by Region
2.2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Region (2017-2022)
2.2.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Region (2023-2028)
2.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Dynamics
2.3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Industry Trends
2.3.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
2.3.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
2.3.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Revenue
3.1.1 Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Revenue (2017-2022)
3.1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue
3.4 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio
3.4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2021
3.5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Key Players Head office and Area Served
3.6 Key Players Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Solution and Service
3.7 Date of Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Breakdown Data by Type
4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Type (2017-2022)
4.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Breakdown Data by Application
5.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Application (2017-2022)
5.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
6.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
6.2.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
6.2.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
6.2.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
6.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
6.3.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
6.3.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
6.3.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
6.4 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
6.4.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
6.4.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
7.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
7.2.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
7.2.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
7.2.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
7.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
7.3.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
7.3.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
7.3.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
7.4 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
7.4.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
7.4.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
8.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
8.2.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
8.3.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region
8.4.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
9.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
9.2.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
9.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
9.3.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
9.4 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
9.4.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
10.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
10.2.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
10.3.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
10.4.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen NV
11.1.1 Qiagen NV Company Details
11.1.2 Qiagen NV Business Overview
11.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.1.4 Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.1.5 Qiagen NV Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.2.4 GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.2.5 GE Healthcare Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.3.5 Agilent Technologies Recent Developments
11.4 F Hoffman La Roche
11.4.1 F Hoffman La Roche Company Details
11.4.2 F Hoffman La Roche Business Overview
11.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.4.5 F Hoffman La Roche Recent Developments
11.5 Foundation Medicine
11.5.1 Foundation Medicine Company Details
11.5.2 Foundation Medicine Business Overview
11.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.5.5 Foundation Medicine Recent Developments
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Details
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.6.5 Thermo Fisher Scientific Inc. Recent Developments
11.7 Leica Biosystems Nussloch GmBH
11.7.1 Leica Biosystems Nussloch GmBH Company Details
11.7.2 Leica Biosystems Nussloch GmBH Business Overview
11.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.7.5 Leica Biosystems Nussloch GmBH Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
11.8.4 Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
11.8.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PCR
Table 3. Key Players of In-situ Hybridization
Table 4. Key Players of Immunohistochemistry
Table 5. Key Players of Sequencing
Table 6. Key Players of Others
Table 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2017-2022)
Table 11. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2023-2028)
Table 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Trends
Table 14. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
Table 15. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
Table 16. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
Table 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Players (2017-2022)
Table 19. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
Table 20. Ranking of Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Solution and Service
Table 24. Date of Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2017-2022)
Table 28. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2023-2028)
Table 30. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2017-2022)
Table 32. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2023-2028)
Table 34. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
Table 64. Qiagen NV Company Details
Table 65. Qiagen NV Business Overview
Table 66. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 67. Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 68. Qiagen NV Recent Developments
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 72. GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 73. GE Healthcare Recent Developments
Table 74. Agilent Technologies Company Details
Table 75. Agilent Technologies Business Overview
Table 76. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 77. Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 78. Agilent Technologies Recent Developments
Table 79. F Hoffman La Roche Company Details
Table 80. F Hoffman La Roche Business Overview
Table 81. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 82. F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 83. F Hoffman La Roche Recent Developments
Table 84. Foundation Medicine Company Details
Table 85. Foundation Medicine Business Overview
Table 86. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 87. Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 88. Foundation Medicine Recent Developments
Table 89. Thermo Fisher Scientific Inc. Company Details
Table 90. Thermo Fisher Scientific Inc. Business Overview
Table 91. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 92. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 93. Thermo Fisher Scientific Inc. Recent Developments
Table 94. Leica Biosystems Nussloch GmBH Company Details
Table 95. Leica Biosystems Nussloch GmBH Business Overview
Table 96. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 97. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 98. Leica Biosystems Nussloch GmBH Recent Developments
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
Table 102. Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
Table 103. Pfizer Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type: 2021 VS 2028
Figure 2. PCR Features
Figure 3. In-situ Hybridization Features
Figure 4. Immunohistochemistry Features
Figure 5. Sequencing Features
Figure 6. Others Features
Figure 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application: 2021 VS 2028
Figure 8. Oncology Case Studies
Figure 9. Neurological Disorders Case Studies
Figure 10. Cardiovascular Disease Case Studies
Figure 11. Immunological Disorders Case Studies
Figure 12. Others Case Studies
Figure 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Report Years Considered
Figure 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region: 2021 VS 2028
Figure 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Players in 2021
Figure 18. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2021
Figure 20. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 22. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 23. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 24. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
Figure 28. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
Figure 29. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
Figure 30. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ M
  • Global Medical Membrane Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 126
    The report focuses on the Medical Membrane market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover......
  • Global Peak Flow Meters Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 106
    Peak flow meters are used by patients with asthma or other lung disorders. This tool allows physicians to further determine the severity of any lung illness. The report focuses on the Peak Flow Meters market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation ......
  • Global Portable Hyperbaric Chamber Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 124
    Hyperbaric Chambers have traditionally been used to treat decompression sickness and wound healing, but "complementary treatments" are increasingly being prescribed to address other chronic conditions, including brain injury, cerebral palsy, autism, stroke, chronic fatigue, and Lyme disease. The report focuses on the Portable Hyperbaric Chamber market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development......
  • Global Healthcare Facility Stools Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 122
    The report focuses on the Healthcare Facility Stools market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market......
  • Global Laboratory Filtration Devices Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 101
    The report focuses on the Laboratory Filtration Devices market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream mar......
  • Global Hyperthermia Devices Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 98
    Hyperthermia therapy is a type of medical treatment in which body tissue is exposed to higher temperatures in an effort to treat cancer. The report focuses on the Hyperthermia Devices market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement w......
  • Global Core Needle Biopsy Devices Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 101
    The core needle biopsy device is a device that removes tissue from the skin (transcutaneously) to the abnormal area to check for disease. After the tissue sample can be removed from any part of the body, biopsy can be safely performed using imaging such as ultrasound, X-ray, computed tomography (CT) or magnetic resonance imaging (MRI). The report focuses on the Core Needle Biopsy Devices market size, segment size (mainly covering product type, application, and geography), competit......
  • Global Anastomat Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 106
    The report focuses on the Anastomat market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, custo......
  • Global N95 Respirator Mask Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 108
    The report focuses on the N95 Respirator Mask market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs